Vitiligo associated with polycaprolactone-based collagen stimulator filler

Huang, Chun-Hsien; Ng, Chau Yee

doi:10.1016/j.jdcr.2022.04.007

Cited by 2 publications

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…More often around the eyes [15] Cerebral infarction and stroke Most common after accidental injection in the ophthalmic angiosome [16,17] Delayed-onset nodules Various pathologies for inflammatory to infectious or filler migration [18] Discoloration More often seen around the eyes, sometimes due to Tyndall effect, sometimes due to post-inflammatory pigmentary changes [19] Dizziness and pain Unmeet hygienic standards, contaminated filler material [30] Tongue necrosis After injection into the chin, vascular compromise [31] Visual loss Most often after injection into glabella or nose with acute ocular pain, lid ptosis, and ophthalmoplegia due to vascular compromise [32] Vitiligo Reported after polycaprolactone injection [33]…”

Section: Bruisingmentioning

confidence: 99%

Filler Migration after Facial Injection—A Narrative Review

Wollina,

Goldman

2023

Cosmetics

View full text Add to dashboard Cite

Background: The injection of dermal fillers for facial esthetics has become a very popular procedure. Although usually safe in the hands of the experienced user, filler injections may bear a risk of unwanted side effects. Material and Methods: This is a narrative review of dermal filler migration after facial injections. We performed research on the literature on Pubmed and Google Scholar. Inclusion criteria were observational studies, case reports, and clinical trials which investigated the association of facial filler injections to filler migration. Animal studies have not been considered. Intravascular injections were excluded. Results: We identified 28 reports that met the inclusion criteria. The age range of affected patients was 21 to 86 years (mean ± standard deviation: 47 ± 14.8 years). Women were 25 times more reported than males. Hyaluronic acid and polyalkylimide were the most commonly encountered filler substances. Injections into the nose, lips, nasolabial folds, and forehead (including glabella) are more often reported for filler migration than injections into the cheeks. Tear-trough correction bears a risk for orbital migration. The delay from injection to presentation of filler migration was highly variable. Very late filler migration was more commonly seen with permanent fillers than non-permanent products. Conclusions: Filler migration distant from the injection site can occur even several years after the primary treatment. All filler types can be involved. Permanent fillers bear a higher risk of very late filler migration. Migration of permanent fillers needs surgical treatment, while HA fillers respond to hyaluronidase injections. Detailed knowledge of facial anatomy, safer injection techniques, and filler qualities are preventive measures.

show abstract

Section: Bruisingmentioning

confidence: 99%

Filler Migration after Facial Injection—A Narrative Review

Wollina,

Goldman

2023

Cosmetics

View full text Add to dashboard Cite

show abstract

Adverse Events and Satisfaction Outcomes with Calcium Hydroxylapatite and Polycaprolactone Fillers in Facial Aesthetics: A Systematic Review

Zago Sá Fortes,

Cassol Spanemberg,

Cherubini

et al. 2024

Cosmetics

View full text Add to dashboard Cite

Objective: The aim of this study was to systematically review the safety and effectiveness of the injectable biostimulators dermal fillers calcium hydroxyapatite (CaHA) and polycaprolactone (PCL) in facial esthetic procedures. Materials and Methods: Comprehensive electronic searches were executed across six academic databases. The primary outcome focused on safety by examining studies that reported the incidence of adverse events (AEs). The secondary outcome gauged the satisfaction of the patients and injectors by validated esthetic scales. To evaluate biases, the Joanna Briggs Institute Checklist tools were employed. Results: We included a total of 79 studies. In the quantitative assessment of the CaHA, out of 5032 injected patients, 21.8% manifested early AEs, 0.85% experienced delayed reactions, and 0.27% had severe complications. Within the PCL group, consisting of 1119 patients, 83.3% exhibited early AEs, 5.6% had delayed reactions, and none had serious complications. Regarding esthetic satisfaction outcome, both products presented favorable results, but a limited number of studies assessed these data. In the studies evaluated qualitatively, a broad array of AEs were cataloged. Conclusions: The occurrence of serious AEs associated with CaHA and PCL fillers is relatively low. Both CaHA and PCL fillers exhibit favorable safety profiles, with most AEs being transient in nature.

show abstract

Vitiligo associated with polycaprolactone-based collagen stimulator filler

Cited by 2 publications

References 10 publications

Filler Migration after Facial Injection—A Narrative Review

Filler Migration after Facial Injection—A Narrative Review

Adverse Events and Satisfaction Outcomes with Calcium Hydroxylapatite and Polycaprolactone Fillers in Facial Aesthetics: A Systematic Review

Contact Info

Product

Resources

About